ProteoTech Inc. ("ProteoTech"), a privately held biotechnology company developing innovative treatments for amyloid diseases and misfolded protein disorders, announced today that Roger S. Flugel, Ph.D. has been appointed as Chief Executive Officer. Dr. Flugel has also been elected as a Director on the company’s Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
